Sage Therapeutics Inc (SAGE)
8.68
0.00 (0.00%)
USD |
NASDAQ |
Aug 11, 16:00
Sage Therapeutics Shareholders Equity (Quarterly) : 368.74M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | 368.74M |
| March 31, 2025 | 409.85M |
| December 31, 2024 | 465.09M |
| September 30, 2024 | 551.84M |
| June 30, 2024 | 628.06M |
| March 31, 2024 | 705.80M |
| December 31, 2023 | 799.53M |
| September 30, 2023 | 816.66M |
| June 30, 2023 | 984.38M |
| March 31, 2023 | 1.133B |
| December 31, 2022 | 1.253B |
| September 30, 2022 | 1.380B |
| June 30, 2022 | 1.504B |
| March 31, 2022 | 1.619B |
| December 31, 2021 | 1.729B |
| September 30, 2021 | 1.836B |
| June 30, 2021 | 1.930B |
| March 31, 2021 | 2.003B |
| December 31, 2020 | 2.072B |
| September 30, 2020 | 657.58M |
| June 30, 2020 | 739.92M |
| March 31, 2020 | 849.21M |
| December 31, 2019 | 944.66M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.081B |
| June 30, 2019 | 1.203B |
| March 31, 2019 | 1.320B |
| December 31, 2018 | 862.97M |
| September 30, 2018 | 988.50M |
| June 30, 2018 | 1.078B |
| March 31, 2018 | 1.059B |
| December 31, 2017 | 475.48M |
| September 30, 2017 | 200.05M |
| June 30, 2017 | 260.30M |
| March 31, 2017 | 318.45M |
| December 31, 2016 | 368.52M |
| September 30, 2016 | 413.74M |
| June 30, 2016 | 257.21M |
| March 31, 2016 | 287.50M |
| December 31, 2015 | 173.70M |
| September 30, 2015 | 198.10M |
| June 30, 2015 | 217.45M |
| March 31, 2015 | 106.51M |
| December 31, 2014 | 121.88M |
| September 30, 2014 | 132.92M |
| June 30, 2014 | 47.68M |
| March 31, 2014 | 53.65M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Abeona Therapeutics, Inc. | 128.06M |
| America Great Health | -4.798M |
| Acumen Pharmaceuticals, Inc. | 57.26M |
| Aardvark Therapeutics, Inc. | 74.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 422.92M |
| Total Liabilities (Quarterly) | 54.18M |